Associations between single-nucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals

References

• Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Kimura S, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T, . Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 2002; 51:536–40.
   PubMed Web of Science ®Google Scholar
• Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G, . Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 2003; 52:1779–85.
   PubMed Web of Science ®Google Scholar
• Sheng T, Yang K, . Adiponectin and its association with insulin resistance and type 2 diabetes. J Genet Genom. 2008; 35:321–6.
   PubMed Web of Science ®Google Scholar
• Yoona SJ, Lee HS, Lee SW, Yun JE, Kim SY, Cho ER, . The association between adiponectin and diabetes in the Korean population. Metabol Clin Exp. 2008; 57:853–7.
   Google Scholar
• Jalovaara K, Santaniemi M, Timonen M, Jokelainen J, Kesäniemi YA, Ukkola O, . Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. Metabol Clin Exp. 2008; 57:1130–4.
   Google Scholar
• Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A, . Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004; 27:2450–7.
   PubMed Web of Science ®Google Scholar
• Saito K, Tobe T, Minoshima S, Asakawa S, Sumiya J, Yoda M, Nakano Y, Shimizu N, Tomita M, . Organization of the gene for gelatin-binding protein (GBP28). Gene. 1999; 229:67–73.
   Google Scholar
• Schaffler A, Langmann T, Palitzsch KD, Scholmerich J, Schmitz G, . Identification and characterization of the human adipocyte apM-1 promoter. Biochim Biophys Acta. 1998; 1399:187–97.
   Google Scholar
• Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, De Matos F, Durand E, Leprete F, Lecoeur C, Gallina P, Zekiri L, Dina C, Froquel P, . Genome wide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21–q24. Am J Hum Genet. 2000; 67:1470–80.
   PubMed Web of Science ®Google Scholar
• Francke S, Manraj M, Lacquemant C, Lecoeur C, Lepretre F, Passa P, Hebe A, Corset L, Yan S, Lahmidi S, Jankee S, Gunness TK, Ramjuttun US, Balgobin V, Dina C, Froguel P, . A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet. 2001; 10:2751–65.
   PubMed Web of Science ®Google Scholar
• Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, Comuzzie AG, . Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA. 2000; 97:14478–83.
   PubMed Web of Science ®Google Scholar
• Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, Boutin P, Vaxillaire M, Leprêtre F, Dupont S, Hara K, Clément K, Bihain B, Kadowaki T, Froguel P, . Single nucleotide polymorphisms haplotypes in the both proximal promoter and exon 3 of APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet. 2002; 11:2607–14.
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M, Machicao F, Haring H, . Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes. 2002; 51:37–41.
   PubMed Web of Science ®Google Scholar
• Filippi E, Sentinelli F, Trischitta V, Romeo S, Arca M, Leonetti F, Di Mario U, Baroni MG, . Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet. 2004; 12:199–205.
   PubMed Web of Science ®Google Scholar
• Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ, Park HJ, Youn BS, Lee HK, Park KS, Shin HD, . Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet Med. 2005; 22:569–75.
   PubMedGoogle Scholar
• Schaffler A, Herfarth H, Paul G, Ehlinq A, Muller-Lander U, Zietz B, . Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2. Exp Clin Endocrinol Diabetes. 2004; 112:383–9.
   Google Scholar
• Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, . Adiponectin I164 T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol. 2004; 43:1195–200.
   PubMedGoogle Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, . Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412–9.
   PubMed Web of Science ®Google Scholar
• Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, Comuzzie AG, . Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA. 2000; 97:14478–83.
   PubMed Web of Science ®Google Scholar
• Comuzzie AG, Funahashi T, Sonnenberg G, Martin LJ, Jacob HJ, Black AE, Maas D, Takahashi M, Kihara S, Tanaka S, Matsuzawa Y, Blangero J, Cohen D, Kissebah A, . The genetic basis of plasma variation in adiponectin, a global end phenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab. 2001; 86:4321–5.
   PubMed Web of Science ®Google Scholar
• Menzaghi C, Ercolino T, Paola RD, Berg AH, Waaram JH, Scherer PE, Trischitta V, Doria A, . A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002; 51:2306–12.
   PubMed Web of Science ®Google Scholar
• Gu HF, Abulaiti A, Ostenson CG, Humphreys K, Whetted C, Brookes AJ, Effendi S, . Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes. 2004; 53(Suppl. 1):S31–5.
   Google Scholar
• Populaire C, Mori Y, Dina C, Vasseur F, Vaxillaire M, Kadowaki T, Froguel P, . Does the −11377 promoter variant of APM1 gene contribute to the genetic risk for type 2 diabetes mellitus in Japanese families?. Diabetologia. 2003; 46:443–5.
   Google Scholar
• Hu FB, Doria A, Li T, Meigs JB, Liu S, Memisoglu A, Hunter D, Manson JE, . Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes. 2004; 53:209–13.
   PubMed Web of Science ®Google Scholar
• Kang ES, Park SY, Kim HJ, Ahn CW, Nam M, Cha BS, Lim SK, Kim KR, Lee HC, . The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care. 2005; 28:1139–44.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T, . The fat-derived hormone adiponectin reverses insulin resistance associated with lipoatrophy and obesity. Nat Med. 2001; 7:941–6.
   PubMed Web of Science ®Google Scholar
• Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF, . Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001; 98:2005–10.
   PubMed Web of Science ®Google Scholar
• Yang WS, Hsiung CA, Ho LT, Chen YT, He CT, Curb JD, Grove J, Quertermous T, Chen YD, Kuo SS, Chuang LM, . Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study. Diabetologia. 2003; 46:977–83.
   PubMed Web of Science ®Google Scholar
• Menzaghi C, Ercolino T, Salvemini L, Coco A, Kim SH, Fini G, Doria A, Trischitta V, . Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomi. 2004; 19:170–4.
   PubMedGoogle Scholar
• Gonzalez-Sanchez JL, Martinez-Calatrava MJ, Martinez-Larrad MT, Zabena C, Fernandez-Perez C, Laakso M, Serrano-Rios M, . Interaction of the-308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population. Clin Chem. 2006; 52:97–103.
   PubMedGoogle Scholar
• González-Sánchez JL, Zebena CA, Martínez-Larrad MT, Fernández-Pérez C, Pérez-Barba M, Laakso M, Manuel Serrano-Ríos, . An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res. 2005; 13:807–13.
   PubMedGoogle Scholar